Really appreciate your research and posting on hotcopper. I have done my own research on Cynata and like what I see. Just trying to work out if it is better to buy more now or when the company is relisted. Thoughts anyone?
Just because the placement was done at 40c doesn't mean that the shares will list at that price. I assume they will list at 20x the last price of ECQ. The $6M placement should see them through without any further dilution for a while. IMO, when listed, they will be one of the lowest value stem cell companies around with one of the most profitable platforms.
I know someone in Qld who is receiving stem cell therapy as a last resort. Their own cells were harvested which I assume is a longer and most costly process than off the shelf therapy. As previously highlighted I like the fact that MSC's can potentially be used as a drug delivery carrier as they are not recognised by the body as foreign.
ECQ Price at posting:
2.4¢ Sentiment: LT Buy Disclosure: Held
